BGNE Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BGNE shares is 344, representing 46.91% of the company's common stock.

BARINGS LLC, in the last quarter, reduced its stake in BGNE by -48.49% restricting it's holding to 31.1 thousand shares of worth nearly $4.86M. SEI INVESTMENTS CO also lessened -60.6% of the BGNE shares from its portfolio, reducing its holding to 23.4 thousand shares of worth $3.66B. HANDELSBANKEN FONDER AB also shunned BGNE shares holding by -2.47% last quarter which brought its holding to 20.75 thousand shares worth $3.25M.

As per its latest 13F filing, INTEGRAL HEALTH ASSET MANAGEMENT, LLC increased its stake in BGNE by 100% in the last quarter. The institutional holder raised its holding to 40 thousand shares having worth more than $6.26M. MACQUARIE GROUP LTD also added 55.14% more shares of BGNE to its portfolio, raising its holding to 45.67 thousand shares of worth $7.14M. GEODE CAPITAL MANAGEMENT, LLC also increased its BGNE shares holding by 0.98% which brought its holding to 36.08 thousand shares worth $5.64M.

The insider with the most stakes in BGNE is HHLR ADVISORS, LTD. , 10 percent owner at the company. Additionally, BGNE stock is highly held by director BAKER BROS. ADVISORS LP and CMO, Hematology Huang Jane among others.

Company executives, directors, and other insiders own 19.43% percent of BeiGene, Ltd.'s stock. Within the last six months, there have been 13 transaction(s) in which BGNE insiders have sold stock, totaling 17.95M shares. Insiders that have sold shares include WANG XIAODONG, BAKER BROS. ADVISORS LP, and WU XIAOBIN.

There have been 0 transaction(s) during the past 6-months in which BeiGene, Ltd. insiders have bought stock, totalling 0 shares

Around 125.84M BeiGene, Ltd. shares are held by insiders, which represents about 19.43% of BGNE stock.

BGNE 10 percent owner, HHLR ADVISORS, LTD. holds the largest portfolio of the company's shares. BGNE shares owned by HHLR total nearly 125.05 million.

INTEGRAL HEALTH ASSET MANAGEMENT, LLC is the largest institutional owner in BGNE which holds 40 thousand shares worth $6.26M or 0.04% of the total BGNE shares outstanding followed by MACQUARIE GROUP LTD with ownership of 45.67 thousand shares representing 0.04% of the BGNE ownership. GEODE CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 36.08 thousand shares or 0.03% of the ownership worth more than $5.64M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BGNE is concerned, it is a stock which is optionable.

Number of BGNE shares short is 1.38M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 97.68M shares of BGNE are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BGNE has 748.93M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BGNE is 3.06.